Joseph Mashni

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 412 citations · Full text

Urology, Oncology, Genitourinary Cancer +2

Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer

Katie S. Murray, Behfar Ehdaie, John E. Musser et al. · The Journal of Urology · 2016 · 71 citations · Full text

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar et al. · The Journal of Urology · 2024 · 64 citations · Full text

Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma

Michael Chevinsky, Mariam Imnadze, Alexander Sankin et al. · The Journal of Urology · 2015 · 48 citations · Full text

Adult Prostate Sarcoma: The Memorial Sloan Kettering Experience

John E. Musser, Melissa Assel, Joseph Mashni et al. · Urology · 2014 · 48 citations · Full text

Urology, Surgical Oncology, Adult Prostate Sarcoma +4